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Abstract Heat shock protein 70 (Hsp70) and heat shock
protein 40 (Hsp40) function as molecular chaperones
during the folding and trafficking of proteins within most
cell types. However, the Hsp70–Hsp40 chaperone partner-
ships within the malaria parasite, Plasmodium falciparum,
have not been elucidated. Only one of the 43 P. falciparum
Hsp40s is predicted to be a cytosolic, canonical Hsp40
(termed PfHsp40) capable of interacting with the major
cytosolic P. falciparum-encoded Hsp70, PfHsp70. Consistent
with this hypothesis, we found that PfHsp40 is upregulated
under heat shock conditions in a similar pattern to PfHsp70.
In addition, PfHsp70 and PfHsp40 reside mainly in the
parasite cytosol, as assessed using indirect immunofluores-
cence microscopy. Recombinant PfHsp40 stimulated the
ATP hydrolytic rates of both PfHsp70 and human Hsp70
similar to other canonical Hsp40s of yeast (Ydj1) and human
(Hdj2) origin. In contrast, the Hsp40-stimulated plasmodial
and human Hsp70 ATPase activities were differentially
inhibited in the presence of pyrimidinone-based small
molecule modulators. To further probe the chaperone
properties of PfHsp40, protein aggregation suppression
assays were conducted. PfHsp40 alone suppressed protein
aggregation, and cooperated with PfHsp70 to suppress
aggregation. Together, these data represent the first cellular
and biochemical evidence for a PfHsp70–PfHsp40 partner-
ship in the malaria parasite, and furthermore that the
plasmodial and human Hsp70–Hsp40 chaperones possess
unique attributes that are differentially modulated by small
molecules.
Keywords Aggregation . ATPase . Codon harmonisation .
Heat shock protein .Malaria .Molecular chaperone
Abbreviations
BSA Bovine serum albumin
DAPI 4′6-Diamidino-2-phenylindole
DMSO Dimethyl sulphoxide
Hsp40 Heat shock protein 40




Electronic supplementary material The online version of this article
(doi:10.1007/s12192-010-0250-6) contains supplementary material,
which is available to authorized users.
M. Botha : L. L. Stephens :G. L. Blatch (*)
Biomedical Biotechnology Research Unit,




A. N. Chiang : P. G. Needham : J. L. Brodsky
Department of Biological Sciences, University of Pittsburgh,
Pittsburgh, PA, USA
H. C. Hoppe
Council for Scientific and Industrial Research,
Pretoria, South Africa
S. Külzer : J. M. Przyborski :K. Lingelbach




Department of Chemistry, University of Pittsburgh,
Pittsburgh, PA, USA
A. Shonhai
Department of Biochemistry and Microbiology,
University of Zululand,
Kwadlangezwa, South Africa




Ni-NTA Nickel-nitrilotriacetic acid beads
PBS Phosphate-buffered saline
PMSF Phenyl methyl sulphonyl fluoride
SDS–PAGE Sodium dodecyl sulphate–
polyacrylamide gel electrophoresis
TRITC Tetramethyl rhodamine isothiocyanate
Introduction
Plasmodium falciparum causes cerebral malaria in humans,
and nearly all malaria deaths result from infection by this
species (Snow et al. 2005). The parasite is adapted to
survive in the stressful environment it encounters in the
human host, and studies suggest that acute temperature
increases, especially those associated with febrile episodes,
augment parasite development and infectivity (Pavithra et
al. 2004). These elevated temperatures invoke the increased
expression of heat shock proteins. Through their action as
molecular chaperones, it has been proposed that heat shock
proteins enable the parasite to become resilient to subse-
quent physiological threats, thereby enhancing parasite
pathogenicity (Pavithra et al. 2004). Consequently, molec-
ular chaperones such as heat shock protein 70 (Hsp70)
together with co-chaperone partners, such as Hsp40, are
likely to provide a cytoprotective role in the adaptation of
the parasite to its human host (Shonhai et al. 2007). It has
also been reported that anti-malarial drugs invoke oxidative
stress in the parasite, consequently inducing heat shock
proteins, including a P. falciparum Hsp70 (Akide-Ndunge
et al. 2009). Furthermore, P. falciparum Hsp70 and Hsp90
proteins associate with ferriprotoporphyrin IX (FPIX; a
degradation product of the malaria parasite), in response to
the effect of chloroquine (Famin and Ginsburg 2003).
Overall, these observations suggest that heat shock proteins
play a key role in the management of toxicity conferred by
drugs to the parasite, and may augment drug resistance. In
addition to their role within the parasite, growing evidence
suggests that parasite heat shock proteins are involved in
the trafficking of parasite-encoded proteins to the erythro-
cyte surface, thus playing a key role in the pathogenesis of
P. falciparum malaria (de Koning-Ward et al. 2009; Külzer
et al. 2010; Maier et al. 2008). Taken together, these
observations suggest that heat shock proteins from P.
falciparum are potential anti-malarial drug targets (Pesce
et al. 2010; Shonhai 2010).
Hsp70 proteins are ubiquitous, highly conserved proteins
found in all major organelles, and play well defined roles in
nascent polypeptide folding, protein translocation, protein
degradation and signal transduction (Kabani and Martineau
2008). Constitutive and inducible Hsp70s are vital for the
maintenance of proteostasis under both normal and stressful
conditions. A typical Hsp70 possesses a molecular mass of
70 kDa and consists of two distinct domains—the 45-kDa
N-terminal ATP-binding domain and 25-kDa peptide-
binding domain, which includes a C-terminal “lid” to
entrap peptide substrates (Flaherty et al. 1990; Wang et al.
1993). When bound to ADP, Hsp70s display high affinity
for substrate, but can release the substrate in their low-
affinity ATP-bound form. In the absence of substrate and
co-chaperone, ATP hydrolysis is a rate-limiting step
because Hsp70s possess a low basal ATPase activity. To
modulate peptide substrate binding and subsequent release,
the ATPase domain of Hsp70 interacts with several co-
chaperones that regulate its nucleotide-bound state, such as
nucleotide exchange factors and Hsp40s (Brodsky and
Bracher 2007; Hennessy et al. 2005). The binding of Hsp40
through a site in the underside of the ATPase domain of
Hsp70 stimulates the ATP hydrolytic activity of Hsp70 to
generate a stable Hsp70–ADP–substrate complex (Jiang et
al. 2007; Landry 2003; Li et al. 2009; Wittung-Stafshede et
al. 2003). Hsp40 is believed to bind to substrates, handing
them over to Hsp70, thus regulating Hsp70 functional
specificity. This model is corroborated by the fact that cells
have fewer Hsp70s compared to Hsp40s.
The Hsp40 family of proteins is defined by the presence
of a highly conserved, ~70 residue J domain (Hennessy et
al. 2005). The J domain is the minimum region of an Hsp40
essential for Hsp70 interaction (Landry 2003). A highly
conserved feature of the J domain, the HPD motif, is
important for the interaction of Hsp40 with Hsp70. The
Escherichia coli Hsp40 (also called DnaJ) is the prototypical
Hsp40, and hence, other Hsp40s are classified based on their
structural organisation relative to DnaJ (Cheetham and Caplan
1998). Type I Hsp40s possess the same structural compo-
nents as DnaJ: they harbour the J domain, a glycine–
phenylalanine (G/F)-rich region, a cysteine repeat domain
and a C-terminal domain, all organised in a similar fashion
as in DnaJ. Type II Hsp40s are similar to DnaJ over the J
domain and the G/F-rich region. Type III proteins have only
a J domain in common with DnaJ, which can be present
anywhere in the protein. Type IV Hsp40s represent a newly
described class of Hsp40s that possess a J-like domain in
which the HPD motif is not conserved (Botha et al. 2007).
Type I and type II Hsp40s are capable of targeting substrates
to Hsp70s and stimulating ATP hydrolysis so as to
ensure effective coupling of hydrolysis to substrate
capture (Hennessy et al. 2005; Walsh et al. 2004).
The P. falciparum genome encodes six Hsp70 proteins,
and 43 Hsp40 and Hsp40-like proteins (Botha et al. 2007;
Shonhai et al. 2007). The major cytosolic Hsp70, which we
will denote PfHsp70 (also called PfHsp70-1; PF08_0054),
is a highly abundant protein expressed at all erythrocytic
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stages of the parasite lifecycle under normal conditions, with
increased levels under heat shock conditions (Kumar et al.
1991). Biochemical evidence from in vitro and in vivo assay
systems conducted in our laboratory has shown that PfHsp70
exhibits the properties of a bona fide Hsp70 molecular
chaperone. In particular, it possesses ATPase activity and is
capable of preventing protein aggregation (Matambo et al.
2004; Shonhai et al. 2005, 2008). Interestingly, the biochem-
ical properties of PfHsp70 suggest that it is distinct from
human Hsp70 (HsHsp70) and may be more responsive to
fluctuations in ATP levels and co-chaperone modulation
(Matambo et al. 2004; Shonhai et al. 2005).
Much of the pathology of P. falciparum infection is
caused by increased “stickiness” of infected cells to
endothelial cells (Miller et al. 2002). This so-called
cytoadherence is mediated by proteins which are exported
from the parasite to the host cell (Crabb et al. 1997). The
mechanism by which the malaria parasite shuttles its
proteins to the erythrocyte surface remains largely unclear,
but seems to rely on export of a further number of parasite
proteins, which appear to function as an “extracellular”
secretory system (Maier et al. 2008). Amongst the
approximately 250 proteins suggested to be exported to
the host cell are 19 members of the Hsp40 family (Botha et
al. 2007; Hiller et al. 2004; Marti et al. 2004). Specific
members of this family are important for parasite proliferation,
whilst others appear to be involved in pathogenesis (Maier et
al. 2008; Silva et al. 2005). It has been suggested that certain
of these exported Hsp40s, especially the type IIs, may work
with HsHsp70 in the transport, folding and assembly of other
exported malarial proteins (Külzer et al. 2010).
We and others have speculated on the existence of
chaperone networks in P. falciparum-infected erythrocytes
(Acharya et al. 2007; Pavithra et al. 2007; Shonhai et al.
2007). However, despite the potential central role of
Hsp70–Hsp40 chaperone pathways in protein folding and
trafficking in the malaria parasite, there is limited experi-
mental evidence for any partnerships. Studies in our
laboratory have provided the first evidence for an Hsp40
partner of PfHsp70. Pfj4, a specialised type II Hsp40, was
found to have a functional J domain (Nicoll et al. 2007), to
be heat-inducible, and to occur in a common complex with
PfHsp70 in P. falciparum-infected erythrocytes (Pesce et al.
2008). P. falciparum encodes only two type I Hsp40s,
neither of which are predicted to be exported (Botha et al.
2007). The type I Hsp40, Pfj1 (PFD0462w), was first
described by Watanabe (1997), and represents a relatively
large, atypical type I Hsp40 containing extensive N- and C-
terminal extensions (Figure S1). Recently, Pfj1 was shown
to be associated with the apicoplast genome (Kumar et
al. 2010). Recombinant Pfj1 was found to have a
functional J domain (Nicoll et al. 2007) and to stimulate
the in vitro protein refolding activity of PfHsp70 (Misra
and Ramachandran, 2009). However, since there is evidence
that Pfj1 is localised to the apicoplast (Kumar et al. 2010), it
is unlikely to associate with cytosolic PfHsp70 in vivo. The
other type I Hsp40 (termed PfHsp40 here; PF14_0359)
possesses all the canonical features of a typical cytosolic co-
chaperone involved in assisting Hsp70s in maintaining
proteostasis (Figure S1). Since PfHsp40 has not been
characterised, we have investigated its potential to function-
ally interact with PfHsp70. Furthermore, we investigated the
effect of small molecule modulators on the PfHsp70–
PfHsp40 partnership in comparison to the human Hsp70–
Hsp40 system. Our data provide the first evidence that
PfHsp40 partners with PfHsp70, and that the plasmodial and
human chaperone systems can be differentially inhibited.
Materials and methods
Antibody design
To raise antibodies specific to PfHsp40, a peptide immunogen
was designed based on a region of high antigenicity and low
conservation located in the C terminus of the protein (Figure
S1). An epitopic region of PfHsp40 was selected using
algorithms for determining peptide antigenicity, surface
probability, hydropathy and chain flexibility as provided in
the GeneRunner software (version 3.05; Hastings Software
Inc.). The peptide [C]SPVDKEYIKVRVTKwas synthesised,
in which the [C] represents a cysteine residue preceding the
target epitopic site. The peptide was subsequently conjugated
to haemocyanin, and polyclonal antibodies were raised in
rabbits in the laboratory of Professor Richard Zimmerman
(Universität des Saarlandes, Germany).
Maintenance of parasite cultures
P. falciparum (strain 3D7) parasites were cultured in A+
human erythrocytes at a haematocrit of 4% in RPMI media
supplemented with 10% A+ human serum, 200 μM hypoxan-
thine and 20 μg/ml gentamicin, at 37°C under N2 containing
5% (v/v) CO2 and 5% (v/v) O2. Cultures were synchronised
during the ring stage of parasite development with sorbitol as
previously described (Lambros and Vandeberg 1979). For
western blot analyses, heat shock was performed by incubat-
ing subcultures at 37°C (control), 41°C (heat shock) and 43°C
(heat shock) for 1 and 2 h. For immunofluorescence assays,
heat shock was performed by incubating subcultures at 37°C
(control) and 42°C (heat shock) for 2 h.
Preparation of P. falciparum lysates
The parasite-infected erythrocytes were treated with 0.1%
(w/v) saponin in phosphate-buffered saline (PBS) to lyse the
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erythrocyte membranes. Subsequently, intact parasites were
sedimented by centrifugation (2,800×g, for 5 min), the
supernatant discarded, and the parasite pellet washed of
excess saponin with PBS. All samples were prepared for
sodium dodecyl sulphate–polyacrylamide gel electrophoresis
(SDS–PAGE) and western blot analysis by reconstitution in
PBS, before treatment by boiling in SDS–PAGE denaturing
and reducing sample buffer. To ensure that lysate fractions
were comparable, equivalent concentrations of proteins or
cells were analysed. PfHsp40 was detected by western blot
analysis using the rabbit polyclonal anti-PfHsp40 primary
antibody (1:5,000 dilution), and horseradish peroxidase
(HRP)-conjugated goat anti-rabbit secondary antibody
(1:5,000 dilution; GE Healthcare). PfHsp70 was detected
by western blot analysis as previously described (Pesce et al.
2008), and served as a positive control for the heat shock
condition. Glycophorin (an erythrocyte membrane protein
that associates with isolated parasites) was detected as a
loading control using a mouse monoclonal anti-human
glycophorin A/B antibody (1:500; Sigma), and an HRP-
conjugated sheep anti-mouse secondary antibody (1:5,000;
GE Healthcare).
Indirect immunofluorescence assays
Indirect immunofluorescence staining, microscopy and
image manipulation were carried out as previously de-
scribed (Külzer et al. 2010), using the purified IgG fraction
of rabbit anti-PfHsp40 antibody (1:100) and cyanine 3
(Cy3)-conjugated goat anti-rabbit secondary antibody
(1:2,000; Dianova). The samples were co-stained with
Hoechst 33258 (50 ng/ml) to detect parasite nuclei. Back-
ground and nonspecific fluorescence signals were monitored
in control experiments with rabbit pre-immunisation serum
used in place of the primary antibody, and in the absence of the
primary antibody.
Hsp40 and Hsp70 proteins
Recombinant hexahistidine-tagged (His6) PfHsp40
(PF14_0359) was purified as described below, and recombi-
nant HsHsp70-His6 (HSPA1A) was purified as previously
described (Chiang et al. 2009). Recombinant His6-PfHsp70
(PF08_0054) was purified under denaturing conditions as
published (Matambo et al. 2004) with modifications (Chiang
et al. 2009) for ATPase assays, and under nondenaturing
conditions as previously described (Shonhai et al. 2008) for
aggregation suppression assays. Yeast Ydj1 was kindly
provided by Dr. D. Cyr (University of North Carolina
Medical School, USA), whilst human Hdj2 was purchased
(Assay Designs). The His6-Hsj1a-encoding expression
plasmid (pQE30-Hsj1a) was prepared by polymerase
chain reaction (PCR) amplification of the coding region
for human Hsj1a using a previously described plasmid
construct as a template (kindly provided by Dr M.E.
Cheetham, University College London, UK; Cheetham et al.
1994), and insertion of the product between the Bam HI and
Hind III sites of pQE30 (McNamara 2006). Recombinant
His6-Hsj1a was purified using standard nickel affinity
chromatography procedures under nondenaturing conditions
(McNamara 2006).
Codon harmonisation and plasmid construction
The PfHsp40 coding region was codon-harmonised (Angov
et al. 2008) for improved heterologous expression in E. coli
by Dr. Evelina Angov (Walter Reed Army Institute of
Research, MA, USA). The codon harmonisation was
confirmed with use of the GeneSplitter software package,
kindly provided by the developer, Professor Jaco de Ridder
(University of Pretoria, South Africa). To facilitate insertion
of the coding region into the pQE30 expression vector
(Qiagen), Bam HI and Hind III restriction sites were
engineered into the sequence. The codon-harmonised
PfHsp40 coding sequence was synthesised by Inqaba
Biotechnical Industries (South Africa) and inserted into
the PCR-Smart cloning vector (Lucigen) to produce
plasmid pPCR–Smart–PfHsp40. The insert was excised
from the plasmid with Bam HI and Hind III restriction
enzymes (Fermentas), and ligated into Bam HI/Hind III-
digested pQE30 expression vector (Qiagen) to produce
plasmid pQPfHsp40. DNA sequencing was employed to
verify the integrity of the coding sequence.
Heterologous expression and purification
Recombinant His6-PfHsp40 protein for protein aggregation
suppression assays was purified from E. coli XL1-Blue
(pQPfHsp40) grown at 26°C in Luria–Bertani media (LB;
1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v)
NaCl) supplemented with 200 μg/ml ampicillin. Protein
expression was induced with 1 mM isopropyl-1-thio-β-D-
galactopyranoside (IPTG) in early log phase (A600<0.6) in
the presence of selection pressure, and the cells were
harvested 16 h post-induction. Protein purification was
performed in batch, under denaturing conditions (4 M urea)
in the presence of 0.1% (v/v) PEI for protein solubilisation,
10 mM imidazole, 300 mM NaCl and 10 mM Tris–Cl
(pH 8.0). Cell lysis was achieved by sonication and
treatment with 1 mM lysozyme, which included a freeze–
thaw step at −20°C, in the presence of proteinase inhibitors
(1 mM phenyl methyl sulphonyl fluoride (PMSF), 0.5 μg/
ml pepstatin A and 1 μg/ml leupeptin). The cell lysate was
clarified by centrifugation (16,000×g, 20 min, 4°C), before
being allowed to bind to nickel-nitrilotriacetic acid beads
(Ni-NTA; Qiagen) at a ratio of 1:4,000 beads to culture
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volume for 4 h at 4°C with gentle agitation. The beads were
subsequently washed consecutively with incremented con-
centrations of imidazole (50, 100 and 150 mM), 50 mM
HEPES, 10 mM ATP and 1% (v/v) Triton X-100,
respectively, in 300 mM NaCl and 10 mM Tris-Cl (pH 8.0).
Protein elution, with 1 M imidazole, was subsequently
performed in the absence of urea to permit protein refolding.
The fractions containing PfHsp40 were dialysed overnight at
4°C against 50 mM Tris–HCl pH 7.4, 50 mM NaCl, 2 mM
MgCl2, 0.8 mM DTT and 5% (v/v) glycerol, and the protein
was concentrated with polyethylene glycol (PEG-3000;
Sigma-Aldrich).
For ATPase assays, PfHsp40 was purified using a
modified protocol. E. coli M15 (pRep4; Qiagen) cells
transformed with pQPfHsp40 were grown at 37°C in
100 ml of LB supplemented with 50 μg/ml ampicillin and
25 μg/ml kanamycin to an A600 of ~0.6. Next, IPTG was
added to a final concentration of 0.4 mM, and growth was
continued at 30°C for 4 h. Cells were pelleted by
centrifugation, quick-frozen, and stored at −80°C. To
isolate the expressed PfHsp40, the cell pellets were thawed
and resuspended in 10 ml of lysis buffer (10 mM Tris,
pH 8.0, 300 mM NaCl, 10 mM imidizole, 8 M urea) and
incubated for 1 h with periodic, gentle agitation to lyse the
cells. The cell lysate was then cleared by centrifugation,
applied to a 1-ml Ni-NTA (Qiagen) column equilibrated in
lysis buffer at 4°C, and allowed to drain through the resin
under gravity. The column was washed with 10 ml of the
lysis buffer, and this step was followed with three 10-ml
washes with decreasing concentrations of urea (4, 2 and
0 M) to allow the protein to refold on the column. The
bound protein was eluted with the lysis buffer lacking urea
but supplemented with 250 mM imidizole. The fractions
containing PfHsp40 were dialysed overnight at 4°C against
50 mM Tris–HCl pH 7.4, 50 mM NaCl, 2 mM MgCl2,
0.8 mM DTT and 5% (v/v) glycerol, and aliquots were
stored at −80°C.
In both protocols, the purity of the recombinant proteins
was verified by SDS–PAGE, and protein integrity and
identity were assessed by western blot analysis using a
mouse monoclonal anti-His tag (1:5,000; GE Healthcare) or
a mouse anti-penta-His (1:5,000; Qiagen) primary antibody
and an HRP-conjugated sheep anti-mouse secondary
antibody (1:5,000; GE Healthcare).
Single-turnover ATPase assays
Single-turnover and steady-state radioactive ATPase assays
were employed to assess the basal and co-chaperone-
stimulated ATPase activities of recombinant HsHsp70 and
PfHsp70. The protocols for the ATPase assays were
adapted from those previously described (Fewell et al.
2004; Wright et al. 2008). In brief, Hsp70–[α32P]ATP
complex was prepared through the incubation of 25 μg of
purified Hsp70 protein with 25 μM ATP (Sigma Scientific)
and 100 μCi of [α32P]ATP (Perkin-Elmer Life Sciences) in
single-turnover complex buffer (STCB; 110 mM MgOAc,
100 mM KCl, 25 mM HEPES, pH 7.5) at 4°C for 30 min.
Unbound [α32P]ATP was eliminated by purification at 4°C
on an illustra™ NICK Sephadex G-50 column (GE
Healthcare) equilibrated in STCB. Eluted fractions of
Hsp70–[α32P]ATP complex were detected with a Geiger
counter, and a 5-μl aliquot was subsequently assayed in a
scintillation counter to confirm peak activity. The fractions
were pooled and supplemented with glycerol to a final
concentration of 10%, and aliquots from the pooled
fractions were quick-frozen. The complex was stored at
−80°C for a period of no longer than 2 weeks prior to use.
For each reaction in which the basal or co-chaperone-
stimulated ATPase activity was determined, a 25-μl aliquot
of Hsp70–[α32P]ATP complex was rapidly thawed at 30°C
and added to 25 μL STCB in a 50–μl reaction. In the co-
chaperone-stimulated reactions, purified Hsp40 (0.3 μM)
was added 60 s after the start of the reaction. The reaction
was allowed to proceed at 30°C, and aliquots of 3 μl were
removed at selected time points throughout a 10-min time
course. ATP hydrolysis was interrupted by treatment with
1 μl of stop solution (SS; 2 M LiCl, 4 M Formic Acid,
36 mM ATP) and a reduction of the reaction temperature to
4°C. Aliquots of the stopped reactions (1 μl) were spotted
in duplicate on thin layer chromatography (TLC) plates and
allowed to develop in TLC buffer (0.5 M LiCl, 1 M formic
acid). The [α32P]ATP isotope was diluted 1:100 and
similarly spotted and developed to determine spontaneous
hydrolysis. Phosphorimager analysis (Fujifilm Phosphor-
imager BAS 2500 coupled to Image Gauge software,
version 4.0) was employed to determine the percentage of
ATP hydrolysed to ADP and Pi in each reaction. Curve fits
and kinetic analyses were performed on the obtained data
using KaleidaGraph (version 3.0.4, Synergy Software).
Kinetic analyses for the co-chaperone stimulated reactions
were performed such that the 60-s time point, which was
when the co-chaperone was added (see above), was
corrected to the zero time point.
Steady-state ATPase assays
Purified recombinant Hsp70 protein (2 μM) was pre-
incubated in reaction buffer (50 mM NaCl, 2 mM
MgCl2, 10 mM DTT, 50 mM HEPES, pH 7.4) for
15 min at 4°C. The reaction was started by the simultaneous
addition of 50 μMATP and 0.01 μCi [α32P]ATP and allowed
to proceed at 30°C over a 50-min time course. At selected
time points, 3-μl aliquots of each reaction were removed and
added to 1 μl of SS at 4°C. The aliquots representing each
time point were subjected to thin layer chromatography
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(in duplicate) and analysed as described above. The data
from each time point were also corrected for spontaneous
ATP hydrolysis. Co-chaperone stimulation of the basal
Hsp70 activity was assessed by the addition of 1 μM of
each Hsp40 to the pre-incubated reaction mixture at 4°C
prior to the addition of ATP. Background ATP hydrolysis
of the co-chaperone protein preparations was assessed
and subtracted accordingly.
Assays of small molecule modulators of ATPase activity
To assess the effects of small molecule modulators that interfere
with the functional interaction between Hsp70 and Hsp40








Mr 790.50; Wright et al. 2008), provided by the Center for
Chemical Methodologies and Library Development at the
University of Pittsburgh, were added into the basal and
co-chaperone-supplemented ATPase assays in the presence of
HsHsp70 or PfHsp70. Single-turnover and steady-state ATPase
assays were conducted as detailed above with the following
exceptions. In single-turnover assays, the compounds MAL3-
39 and DMT002264 were dissolved in dimethyl sulphoxide
(DMSO) and added to a final concentration of 300 μM at the
start of each reaction. In steady-state assays, pre-incubation of
the assay components prior to the addition of ATP was
achieved in the presence of 300 μM of each respective
compound dissolved in DMSO. In all assays, data were
compared to control reactions that contained an equal volume
of DMSO.
Malate dehydrogenase aggregation suppression assays
This assay assessed the ability of individual chaperones and
Hsp70–Hsp40 pairs to suppress the heat-induced aggrega-
tion of malate dehydrogenase (MDH) at 48°C over time.
The MDH (0.72 μM; Roche Applied Sciences, Germany)
and chaperone proteins of interest (0.3 μM respectively)
were suspended in assay buffer (100 mM NaCl, 50 mM
Tris–Cl, pH 7.4) pre-equilibrated to 48°C. The accumulation
of protein aggregates was monitored by changes at A360 in a
thermocontrolled spectrophotometer (Model 14NT-UV–VIS,
Aviv Instruments Inc, Lakewood, NJ, USA). As a reference,
MDH aggregation was monitored in the absence of
chaperones at 48°C over time. Similarly, in the absence of
MDH, the thermal stability of the chaperone proteins under
investigation was assessed to ensure accurate monitoring of
the MDH aggregation in the test experiments. Furthermore,
BSA (0.3 μM) was used to ensure that the observed
suppression of MDH aggregation was chaperone-mediated.
In previous assays (Shonhai et al. 2008), ATP has been
included to demonstrate the nucleotide dependence of the
MDH aggregation suppression; this control was not repeated
here. Protein concentrations were calculated assuming the
monomeric forms of the relevant proteins.
Results
PfHsp40 protein levels are upregulated by heat shock
Antibodies generated to a C-terminal peptide region of
PfHsp40 (Figure S1) were tested by western analyses and
found to specifically detect PfHsp40 (data not shown).
Using these anti-PfHsp40 antibodies, we conducted a
western blot analysis on total protein extracts from parasites
isolated from mixed-stage P. falciparum-infected erythro-
cytes grown in vitro under normal (37°C) and heat shock
(41°C and 43°C) conditions. A single protein band of the
expected molecular mass for PfHsp40 (49 kDa) was
detected in each of the parasite extracts (Fig. 1, upper
panel). As previously reported (Pesce et al. 2008), PfHsp70
was detected in parasite extracts after 37°C growth, and at
increased levels after heat shock (Fig. 1, middle panel).
PfHsp40 was detectable at 37°C, and similar to PfHsp70,
increased protein levels were evident after heat shock at 41°C
and 43°C. However, the expression of both proteins was
slightly reduced at 43°C compared to 41°C after 2 h of heat
Fig. 1 PfHsp40 is upregulated under heat shock conditions. P.
falciparum-infected erythrocytes of mixed stages were grown at 37°
C, 41°C and 43°C for 1 and 2 h, as indicated. Parasites were isolated
from the infected erythrocytes by saponin lysis, and total protein from
equal number of cells was subjected to SDS–PAGE, followed by
western blot analysis using anti-PfHsp40 antibodies (upper panel) and
anti-PfHsp70 antibodies (middle panel). The glycophorin signal was
used as a loading control (lower panel). This experiment was repeated
at least three times, and a representative series of western blots is
shown
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shock compared to 1 h of heat shock. This was possibly due to
parasite death after 2 h at 43°C. The differences in the levels of
PfHsp40 and PfHsp70 for the various treatments were not due
to differences in loading, as the levels of the loading control,
glycophorin, remained relatively unchanged (Fig. 1, lower
panel). Overall, these data indicate that the expression
profiles of PfHsp40 and PfHsp70 are similar.
PfHsp40 is localised to the parasite cytosol in
P. falciparum-infected erythrocytes
We next performed indirect immunofluorescence assays on
P. falciparum-infected erythrocytes using purified IgG from
the newly generated anti-PfHsp40 antiserum. As shown in
Fig. 2, PfHsp40 localised mainly to the parasite cytosol at
the trophozoite stage, and this localization was observed for
parasites subjected to normal and heat shock conditions. A
similar localization was detected for schizont-stage para-
sites (data not shown), and in all cases, the PfHsp40
localization profile was observed at an incidence of at least
90%. In comparison, PfHsp70 is primarily localised to the
parasite cytosol and nucleus (Kappes et al. 1993; Pesce et
al. 2008), and in the current study, we confirmed the
localization of PfHsp70 to the parasite cytosol (data not
shown). Interestingly, PfHsp40 was also occasionally
detected externally to the parasite in the host cell, such as
in punctate structures along the erythrocyte plasma mem-
brane (data not shown). No fluorescence signal was
detected when using the rabbit pre-immune serum, suggesting
that the detection of PfHsp40 in the infected erythrocyte
cytosol was specific. Overall, these data indicate that PfHsp40
resides primarily in the parasite cytosol.
Heterologous expression and purification of PfHsp40
and PfHsp70
To examine the biochemical properties of PfHsp40, the
coding region for PfHsp40 was harmonised for heterolo-
gous expression in E. coli. Recombinant His6-PfHsp40 was
expressed at moderate levels (Figure S2, lane 1), and its
purification was successfully achieved by nickel affinity
chromatography under denaturing conditions to yield
approximately 1 mg of protein per litre of culture (Figure
S2, lanes 2–5). This purification procedure yielded protein
that was free of E. coli Hsp70 (DnaK). Although it was
possible to partially purify His6-PfHsp40 using a non-
denaturing purification procedure, the protein was typically
contaminated with E. coli DnaK (data not shown). In
parallel, recombinant His6-PfHsp70 protein was success-
fully overexpressed and purified using both denaturing and
nondenaturing procedures. Purification of PfHsp70 using
the denaturing procedure had the advantage of stripping the
protein of any bound nucleotide, and therefore, this protein
was ideal for use in the ATPase assays conducted in this
study. Whilst PfHsp70 protein purified under both denatur-
ing and nondenaturing conditions was successfully used in
the protein aggregation suppression assays, to be consistent
with our previous studies (Shonhai et al. 2008), the protein
prepared under nondenaturing conditions was used in the
aggregation assays in this study.
Fig. 2 PfHsp40 resides mainly in the parasite cytosol. Immunofluo-
rescence staining to detect PfHsp40 was conducted on trophozoite
stage P. falciparum-infected erythrocytes. Upper panels parasite-
infected erythrocytes maintained at 37°C, lower panels parasite-
infected erythrocytes incubated at 42°C for 2 h prior to fixation and
staining. PfHsp40 was detected using the rabbit anti-PfHsp40
antibody and Cy3-conjugated goat anti-rabbit secondary antibody
(indicated in red). Parasite nuclei were stained with Hoechst
(indicated in blue). Columns: Phase phase-contrast image, Nucleus
parasite nuclei, PfHsp40 PfHsp40 localization, Merge 1 merged image
indicating PfHsp40 localization relative to the parasite nucleus, Merge
2 merged image indicating PfHsp40 localization relative to the
parasite nucleus and phase-contrast image. A fluorescence signal
was absent in negative controls that employed pre-immunisation
serum as the primary antibody or that examined the signal when only
a secondary antibody was used. The white size bars in each frame
indicate 3 μm. This experiment was repeated at least three times, and a
representative series of images is shown
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PfHsp40 stimulates the rate of ATP hydrolysis of PfHsp70
and HsHsp70
Hsp40 co-chaperones stimulate the rate-limiting ATP hydro-
lysis step in the Hsp70 catalytic cycle, which facilitates
substrate capture. Using single-turnover assays in which this
step is directly measured, we explored the effects of PfHsp40
and other Hsp40s on the ATPase activities of PfHsp70 and
HsHsp70. Besides PfHsp40, the tested Hsp40s included both
human (Hdj2 and Hsj1a) and yeast (Ydj1) Hsp70 co-
chaperones. As anticipated, we first discovered that both
PfHsp70 and HsHsp70 displayed relatively weak, basal rates
of ATP hydrolysis (Fig. 3a, b). His6-Rtf1, a hexahistidine-
tagged yeast protein involved in transcription (Stolinski et al.
1997) that lacks a J domain, served as a negative control and
was unable to stimulate the ATPase activity of either
PfHsp70 or HsHsp70. In contrast, PfHsp40, Hdj2, Ydj1
and Hsj1a stimulated the ATP hydrolytic rates of PfHsp40
and HsHsp70 when used at identical concentrations (Fig. 3a,
b). The type I Hsp40s (PfHsp40, Hdj2 and Ydj1) stimulated
each Hsp70 by comparable magnitudes, and with similar
kinetics. The type II Hsp40, Hsj1a, simulated the ATP
hydrolytic rates of both PfHsp70 and HsHsp70 to a greater
magnitude and with very different kinetics to that observed
for the type I Hsp40s (Fig. 3a, b).
The ATP hydrolytic activities of PfHsp70 and HsHsp70
were also monitored in the presence of the Hsp40 proteins
under steady-state conditions (Fig. 3c, d). Again, the
control protein, His6-Rtf1, did not significantly stimulate
the basal ATP hydrolytic activities of PfHsp70 or HsHsp70
(Fig. 3c, d). In contrast, PfHsp40 moderately stimulated
that ATPase activity of PfHsp70, whilst Hdj2, Ydj1 and
Hsj1a displayed a greater stimulatory effect (Fig. 3c).
PfHsp40 and Hsj1a also moderately stimulated the ATPase
activity of HsHsp70 to a similar extent, whilst Ydj1 and
Hdj2 had a slightly greater stimulatory effect (Fig. 3d).
Thus, although the relative stimulatory effects of each
Hsp40 chaperone on PfHsp70 and HsHsp70 differ some-
what when the steady-state and single-turnover assays are
compared, these data suggest that PfHsp40 interacts with
PfHsp70 in the parasite. The data also indicate that
PfHsp40, like some other Hsp40 co-chaperones (Hennessy
et al. 2005), exhibits promiscuous functional interactions
with evolutionarily diverse Hsp70s.
Pyrimidinone-peptoids differentially modulate
Hsp40-stimulated ATPase activities of PfHsp70
and HsHsp70
Small molecule modulators have been identified that
abrogate the ability of Hsp40s to activate the ATPase
activity of Hsp70s, and some of these agents exhibit distinct
effects on unique Hsp70–Hsp40 pairs (Fewell et al. 2004;
Wright et al. 2008). Consistent with this mode of action,
some members of this pyrimidinone class of Hsp70 modu-
lators have been found to associate with Hsp70 at a region in
the ATPase domain to which J domains bind (Wisén et al.
2010). Moreover, two structurally similar pyrimidinones,
MAL3-39 and DMT002264, have been shown to modulate
Hsp70 chaperone activity, and possess anti-malarial activity
(Chiang et al. 2009). Because these molecules interfere with
chaperone function by binding to a relatively large surface
area on Hsp70 (Wisén et al. 2010), high concentrations of
test compounds are required for these in vitro analyses.
However, differences in their effects on unique chaperone
classes can be used to infer distinct mechanisms of action.
Based on these considerations, we examined the effects
of MAL3-39 and DMT002264 on the Hsp40-stimulated
ATPase activities of PfHsp70 and HsHsp70 (Fig. 4). In the
presence of MAL3-39, PfHsp40-stimulated PfHsp70
ATPase activity was unaffected under both single-turnover
(Fig. 4a) and steady-state conditions (Fig. 4c). MAL3-39
also had no effect on Hdj2-stimulated HsHsp70 activity
under single-turnover conditions (Fig. 4b), but this agent
had a strong inhibitory effect under steady-state conditions
(compare filled diamonds to filled squares, Fig. 4d). The
second compound, DMT002264, inhibited PfHsp40-
stimulated PfHsp70 ATPase activity under single-turnover
conditions (compare filled triangles to filled squares,
Fig. 4a), but had no major effect under steady-state
conditions (Fig. 4c). DMT002264 also had no effect on
Hdj2-stimulated HsHsp70 ATPase activity under single-
turnover conditions (Fig. 4b), but did have an inhibitory
effect under steady-state conditions (compare filled trian-
gles to filled squares, Fig. 4d). Overall, these data suggest
that both MAL3-39 and DMT002264 are capable of
inhibiting the Hdj2-stimulated ATPase activity of HsHsp70
under steady-state conditions, whilst the PfHsp40-
stimulated ATPase activity of PfHsp70 is only inhibited
by DMT002264 under single-turnover conditions. At
present, the nature of the observed selectivity and the
distinct effects on chaperone activity in steady-state versus
single-turnover conditions is not completely clear (see
“Discussion” section). However, we can conclude that the
human and malarial chaperone systems are differentially
inhibited by select members of this class of Hsp70
modulators. This result also suggests the possibility for
enhanced, selective inhibition of PfHsp70–PfHsp40 over
HsHsp70–Hsp40 function. Such selectivity represents the
next step towards the development of chaperone-based,
anti-malarial therapeutics.
PfHsp40 is able to suppress protein aggregation
The ability of PfHsp70 to suppress the heat-induced
aggregation of model proteins in vitro has been documented
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(Ramya et al. 2006; Shonhai et al. 2008). Consequently, we
explored the ability of PfHsp40 to suppress protein
aggregation alone (as reported for other type I Hsp40s; Lu
and Cyr 1998; Walsh et al. 2004), as well as its ability to
enhance the aggregation suppression activity of the Hsp70s.
In these experiments, the aggregation of MDH in the
absence of any added chaperone was set to 100% (Fig. 5).
In the presence of a nonchaperone protein, BSA, we found
MDH aggregation was unaffected (data not shown).
Furthermore, none of the chaperones used in this study
aggregated when tested alone under the assay conditions. In
contrast, PfHsp40 suppressed MDH aggregation when used
alone and was more effective than Hsj1a, which also
suppressed MDH aggregation (Fig. 5; 64.6% versus 81.6%
aggregation, respectively). As previously reported (Shonhai
et al. 2008), PfHsp70 suppressed MDH aggregation, but
when paired with PfHsp40, MDH aggregation was sup-
pressed to a greater level (i.e. only 10% aggregation
observed) than was due to the individual chaperones.
Similarly, HsHsp70 suppressed MDH aggregation (44.6%
aggregation), and in the presence of Hsj1a, there was
greater suppression of MDH aggregation (Fig. 5; compare
44.6% versus 20.3% aggregation). Interestingly, the MDH











































































































Fig. 3 PfHsp40 stimulates the rate of ATP hydrolysis of PfHsp70 and
HsHsp70. The Hsp40-stimulated ATPase activities of PfHsp70 and
HsHsp70 were monitored under single-turnover (a, b) and steady-state
conditions (c, d). The ATPase activities of 2 μM PfHsp70 (a and c) and
2 μM HsHsp70 (b and d) were monitored for the Hsp70 alone (basal
activity; filled circles) as well as in the presence of Hsp40 co-chaperones.
The Hsp40 co-chaperone-stimulated ATP hydrolytic rates of PfHsp70 and
HsHsp70 were monitored in the presence of 0.3 μM (single-turnover) or
1 μM (steady-state) of the co-chaperones PfHsp40 (filled downward
triangles), Hdj2 (filled triangles), Ydj1 (filled squares), and Hsj1a (filled
diamonds), as well as in the presence of a protein that lacks a J domain,
Rtf1 protein (open circles), which was used as a negative control. For the
single-turnover assays, the co-chaperones were added to the reaction mix
after 60 s. Therefore, the results were plotted such that the 60-s time point
was transposed as the zero time point, and all subsequent time points
were considered relative to this time. Curve fits were applied using linear
fits (PfHsp70 alone, HsHsp70 alone, and both Hsp70s with Rtf1), single-
exponential fits (stimulation with PfHsp40, Ydj1, and Hdj2), or two-step
exponential fits (stimulation with Hsj1a). For the steady-state assays, the
Hsp70s alone or in the presence of the co-chaperones or Rtf1 were pre-
incubated for 15 min at 4°C before the reaction was started upon the
addition of ATP. The point at which ATP was added was set to zero, and
curve fits were applied using linear (PfHsp70 alone, HsHsp70 alone, and
both Hsp70s with Rtf1), or single-exponential (stimulation with PfHsp40,
Ydj1, Hdj2, and Hsj1a) fits. Representative curve fits were generated in
KaleidaGraph (version 3.0.4, Synergy Software). This experiment was
repeated at least three times, and the standard deviations are shown as
error bars for each point in all the curves
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homologous Hsp70–Hsp40 pair were close to the sum of
the individual aggregation suppression levels (Fig. 5). One
interpretation is that the chaperone pair was acting
independently in protein aggregation suppression. However,
it cannot be excluded that there was synergistic cooperation
between the chaperones. In comparison, the heterologous
Hsp70–Hsp40 pairs exhibited MDH aggregation suppression
activities that were somewhat less than the additive levels,
especially in the case of the PfHsp70–Hsj1a pair where the
aggregation suppression levels were similar to that of
PfHsp70 alone (Fig. 5; compare 38.2% versus 33.5%
aggregation). Overall, these data provide evidence for the
first time that PfHsp40 alone can suppress protein aggrega-
tion, and that it may cooperate with PfHsp70 in the parasite.
Discussion
For the first time, we provide biochemical and cell
biological evidence for a functional partnership between
the canonical type I plasmodial Hsp40, PfHsp40, and the
major plasmodial Hsp70, PfHsp70. Like PfHsp70, PfHsp40
localised mainly in the parasite, and its protein levels
increased under heat shock conditions. Our findings are
consistent with steady-state mRNA expression profiling
data, which revealed that PfHsp40 is expressed during all
stages of the intra-erythrocytic phase of parasite development,
and that the expression pattern of PfHsp70 is similar (Le Roch
et al. 2003). Importantly, our data also established that the






































































































Fig. 4 The PfHsp70–PfHsp40 and HsHsp70–Hdj2 chaperone ma-
chineries can be differentially inhibited. The effects of the small
organic molecules MAL3-39 and DMT002264 on the Hsp40-
stimulated ATPase activities of PfHsp70 and HsHsp70 were moni-
tored under single-turnover (a, b) and steady-state conditions (c, d).
The assays were conducted in the presence of 2 μM of PfHsp70 alone
(basal activity; filled circles), in the presence of PfHsp40 (1 μM; filled
squares), and in the presence of PfHsp40 (1 μM) and MAL3-39
(300 μM; filled diamonds) or DMT002264 (300 μM; filled triangles;
a and c). The assays were similarly conducted using 2 μM HsHsp70
alone (basal activity; filled circles), in the presence of Hdj2 (1 μM;
filled squares), and in the presence of Hdj2 (1 μM) and MAL3-39
(300 μM; filled diamonds) or DMT002264 (300 μM; filled triangles;
b and d). The curve fits were applied using linear (PfHsp70 and
HsHsp70 alone), or single-exponential fits (stimulation with PfHsp40
and Hdj2 in the absence and presence of MAL3-39 and DMT002264).
Representative curve fits were generated in KaleidaGraph (version
3.0.4, Synergy Software). This experiment was repeated at least three
times, and the standard deviations are shown as error bars for each
point in all the curves
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state mRNA expression profile. Using purified recombinant
protein, we found that PfHsp40 stimulated the basal ATP
hydrolytic activity of PfHsp70 with similar magnitude and
kinetics to that found for other type I Hsp40s with their
Hsp70 partners. Furthermore, PfHsp40 suppressed protein
aggregation and cooperated with PfHsp70 to inhibit the
aggregation of a model protein. These results provide the
strongest evidence to date for the existence of an Hsp70–
Hsp40 pair in the malaria parasite, P. falciparum.
We also found that the type II Hsp40, Hsj1a, stimulated
the ATP hydrolytic activities of both the human and
plasmodial Hsp70s to relatively high levels, and with
complex kinetics. These data are consistent with the fact
that both Hsj1a and its splice variant, Hsj1b, have been
shown to regulate the ATPase and substrate-binding
activities of bovine Hsc70 (Cheetham et al. 1994). These
chaperones also help mediate the degradation of select
clients by the proteasome (Westhoff et al. 2005). In
addition, whilst Hsj1a cooperated with HsHsp70 to sup-
press protein aggregation, the co-chaperone was unable to
function with PfHsp70. Whilst Hsj1b has been shown to
independently suppress protein aggregation (Schnaider et
al. 2000), our experiments showed for the first time that
Hsj1a similarly exhibited this chaperone-dependent property.
Furthermore, Hsj1a was less effective than PfHsp40 in
suppressing protein aggregation alone. Together, many of
these results are consistent with published data that type I
Hsp40s function better as chaperones on their own and are
more effective at forming select chaperone partnerships with
Hsp70 than type II Hsp40s (Lu and Cyr 1998; Rosser and Cyr
2007).
PfHsp40 is not the only Hsp40 co-chaperone that may
partner with PfHsp70. The other type I Hsp40 in P.
falciparum, Pfj1, has also been suggested to partner with
PfHsp70 (Misra and Ramachandran 2009). However, as it
is an atypical type I Hsp40 and resides in the apicoplast
(Kumar et al. 2010), we do not favour the notion that Pfj1 is
a PfHsp70 co-chaperone. However, we have previously
shown that the type II Hsp40, Pfj4, is upregulated under
heat shock conditions and is localised to the parasite
cytosol and nucleus. Interestingly, in contrast to PfHsp40
(data not shown), we were able to detect Pfj4 in a complex
with PfHsp70 after immunoprecipitation was performed
from cell lysates (Pesce et al. 2008). This result suggests
that the interaction between PfHsp70 and PfHsp40 is
transient, as is commonly observed between chaperone
and co-chaperone partners. In addition, and in accordance
with our results, Hsp70s can be modulated by more than
one Hsp40 partner (Hennessy et al. 2005; Walsh et al.
2004). This observation is important in light of the fact that
Hsp40s serve as substrate scanners for Hsp70s (Rüdiger et
al. 2001). Therefore, we suggest that the activity of
PfHsp70 in the parasite is modulated by both PfHsp40
and Pfj4. There may even be additional P. falciparum
Hsp40 partners for PfHsp70, which can now be tested using
the tools developed in this report.
MAL3-39 and DMT002264 are known modulators of
Hsp70 chaperone function and have been shown to exhibit
anti-malarial activity (Chiang et al. 2009). The differential
effects of these small molecules on the ATPase activities of
PfHsp70–PfHsp40 compared to HsHsp70–Hdj2 strongly
suggest that these chaperone partnerships are not identical,
and provide the first side-by-side biochemical evidence for
previous proposals that these plasmodial and human
chaperone machineries are different (Matambo et al. 2004;






















































































Fig. 5 PfHsp40 works more
effectively with PfHsp70 than
HsHsp70 in suppressing protein
aggregation. The degree of
heat-induced (48°C) aggregation of
MDH was monitored in the
presence or absence of the indicat-
ed chaperones. The aggregation of
0.72 μMMDH in the absence of
chaperone proteins at saturation
was assigned a value of 100%. The
aggregation of MDH in the pres-
ence of the Hsp70s alone (0.3μM),
theHsp40s alone (0.3μM), and the
Hsp70–Hsp40 combinations were
assessed at saturation, and the
percentage aggregation was deter-
mined relative to theMDH control.
This experiment was repeated at
least three times, and the average
percent aggregation is indicated
above each bar, with the standard
deviations shown as error bars
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effects in the steady-state and single-turnover ATPase assays
—phenomena that have been observed for other chaperone
pairs (Chiang et al. 2009). Possibly, the conformational
change upon ligand binding in Hsp70 interferes differentially
on nucleotide exchange versus ATP hydrolysis activity. Of
note, the single-turnover assays only measure the kCAT (i.e.
the ATP hydrolytic activity of Hsp70), whereas the steady-
state assays quantify each step in the Hsp70 hydrolytic cycle,
which includes nucleotide release.
Finally, whilst our assays were conducted in the presence
of relatively high concentrations of compound, the data do
provide a basis for the rational development of small
molecule compounds that modulate Hsp70–Hsp40 interac-
tions with greater selectivity and affinity (Wisén et al. 2010).
Since molecular chaperones are emerging anti-malarial drug
targets (Pesce et al. 2010; Shonhai 2010), compounds with
greater selectivity and affinity will represent useful leads in
novel drug discovery. However, more importantly, such
compounds will also be useful as molecular probes for
further dissecting the similarities and differences in the
mechanism of action of plasmodial chaperones compared to
their human homologues. The characterisation of chaperone
partnerships, as performed in our study, provides a platform
for the benchmarking of new “hit compounds” from recent
large-scale screens (Guiguemde et al. 2010) for their
potential effects on chaperone function.
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